Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • Page 711
abbott-launches-ai-based-libre-assist,-its-new-in-app-feature-for-meal-planning
Posted inMedical Technology

Abbott launches AI-based Libre Assist, its new in-app feature for meal planning

January 5, 2026
Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s…
Read More
incretin-modulation-revolutionizes-diabetes,-heart,-and-kidney-health
Posted inBiotechnology

Incretin Modulation Revolutionizes Diabetes, Heart, and Kidney Health

January 5, 2026
Recent advancements in diabetes therapy have taken a significant turn as researchers delve into incretin modulation, revealing its profound potential…
Read More
unveiling-maclura-tricuspidata’s-complete-mitochondrial-genome
Posted inBiotechnology

Unveiling Maclura Tricuspidata’s Complete Mitochondrial Genome

January 5, 2026
In a groundbreaking study, researchers have unveiled the complete mitochondrial genome of Maclura tricuspidata, a plant species common to East…
Read More
ai-predicts-ice-hockey-impact-with-strain-analysis
Posted inBiotechnology

AI Predicts Ice Hockey Impact with Strain Analysis

January 5, 2026
In recent years, the intersection of sports and technology has opened doors to innovative methodologies that enhance performance and safety.…
Read More
zenas’-stock-sinks-in-wake-of-autoimmune-phase-3-data-despite-primary-endpoint-hit
Posted inBiotechnology

Zenas’ stock sinks in wake of autoimmune phase 3 data despite primary endpoint hit

January 5, 2026
A phase 3 study of Zenas BioPharma's autoimmune disease candidate has hit its primary endpoint. But, with the result falling short…
Read More
aktis-oncology-aims-for-$209m-windfall-from-1st-biotech-ipo-of-2026
Posted inBiotechnology

Aktis Oncology aims for $209M windfall from 1st biotech IPO of 2026

January 5, 2026
Aktis Oncology is aiming to bring in $182 million—or more—from what looks set to be the first biotech IPO of…
Read More
efficient-tail-risk-assessment-for-power-systems
Posted inBiotechnology

Efficient Tail Risk Assessment for Power Systems

January 5, 2026
In an era where the reliability and stability of power systems underpin the very fabric of modern society, the capacity…
Read More
novel-clostridium-phages-combat-chicken-meat-contamination
Posted inBiotechnology

Novel Clostridium Phages Combat Chicken Meat Contamination

January 5, 2026
In an era where food safety increasingly comes into focus, researchers have turned their attention to an innovative approach for…
Read More
sanofi’s-latest-autoimmune-bispecific-pact-with-ai-biotech-could-reach-$2.5b
Posted inBiotechnology

Sanofi’s latest autoimmune bispecific pact with AI biotech could reach $2.5B

January 5, 2026
Sanofi has returned to U.S. artificial intelligence research biotech Earendil Labs for another significant autoimmune and immunology development pact. The…
Read More
11-amino-acid-peptides-block-colorectal-cancer-immune-evasion
Posted inBiotechnology

11-Amino-Acid Peptides Block Colorectal Cancer Immune Evasion

January 5, 2026
In a groundbreaking study published in Cell Research, researchers have unveiled a novel approach to thwart immune evasion mechanisms employed…
Read More

Posts pagination

Previous page 1 … 709 710 711 712 713 … 731 Next page

Privacy Policy    Terms

Scroll to Top